{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT04909879",
      "OrgStudyIdInfo": {
        "OrgStudyId": "MSC-ARDS-201"
      },
      "Organization": {
        "OrgFullName": "Sorrento Therapeutics, Inc.",
        "OrgClass": "INDUSTRY"
      },
      "BriefTitle": "Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Non-COVID-19 Acute Respiratory Distress Syndrome",
      "OfficialTitle": "Treatment of Non-COVID-19 Acute Respiratory Distress Syndrome: A Phase 2 Study of the Efficacy and Safety of Intravenous Allogeneic Adipose-Derived Mesenchymal Stem Cells"
    },
    "StatusModule": {
      "StatusVerifiedDate": "September 2021",
      "OverallStatus": "Withdrawn",
      "WhyStopped": "Replaced by a different protocol.",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "September 2021",
        "StartDateType": "Anticipated"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "February 2022",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "April 2022",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "May 29, 2021",
      "StudyFirstSubmitQCDate": "May 29, 2021",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "June 2, 2021",
        "StudyFirstPostDateType": "Actual"
      },
      "LastUpdateSubmitDate": "September 17, 2021",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "September 24, 2021",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Sorrento Therapeutics, Inc.",
        "LeadSponsorClass": "INDUSTRY"
      }
    },
    "OversightModule": {
      "IsFDARegulatedDrug": "Yes",
      "IsFDARegulatedDevice": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "This is a Phase 2 randomized study to assess the safety and efficacy of COVI-MSC in the setting of current standard of care treatments for subjects hospitalized subjects with acute respiratory distress syndrome not related to COVID-19 infection.",
      "DetailedDescription": "This is a Phase 2, randomized controlled, multicenter study to assess the safety and efficacy of COVI-MSC in the setting of current standard of care treatments for subjects hospitalized subjects with acute respiratory distress syndrome not related to COVID-19 infection.\n\nSubjects will be randomized 2:1 to receive COVI-MSC or placebo. COVI-MSC or placebo will be administered intravenously on Day 0, Day 2, and Day 4."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Acute Respiratory Distress Syndrome",
          "Ards"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "ARDS"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 2"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Randomized",
        "DesignInterventionModel": "Parallel Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "Quadruple",
          "DesignWhoMaskedList": {
            "DesignWhoMasked": [
              "Participant",
              "Care Provider",
              "Investigator",
              "Outcomes Assessor"
            ]
          }
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "0",
        "EnrollmentType": "Actual"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "COVI-MSC",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Subjects will receive intravenous infusions of COVI-MSC (two vials or a total of ≈ 30 million cells) on Day 0, Day 2, and Day 4",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: COVI-MSC"
              ]
            }
          },
          {
            "ArmGroupLabel": "Placebo",
            "ArmGroupType": "Placebo Comparator",
            "ArmGroupDescription": "Subjects will receive intravenous infusions of placebo (two vials) on Day 0, Day 2, and Day 4",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Drug: Placebo"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "COVI-MSC",
            "InterventionDescription": "COVI-MSC are allogeneic culture-expanded adipose-derived mesenchymal stem cells",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "COVI-MSC"
              ]
            }
          },
          {
            "InterventionType": "Drug",
            "InterventionName": "Placebo",
            "InterventionDescription": "Excipient solution",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Placebo"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "All-cause mortality rate at Day 28",
            "PrimaryOutcomeDescription": "All-cause mortality rate at Day 28",
            "PrimaryOutcomeTimeFrame": "Baseline to Day 28"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "All-cause mortality rate at Days 60 and 90",
            "SecondaryOutcomeDescription": "All-cause mortality rate at Days 60 and 90",
            "SecondaryOutcomeTimeFrame": "Baseline to Day 60 and Day 90"
          },
          {
            "SecondaryOutcomeMeasure": "Number of ventilator-free days through Day 28",
            "SecondaryOutcomeDescription": "Number of ventilator-free days through Day 28",
            "SecondaryOutcomeTimeFrame": "Baseline through Day 28"
          },
          {
            "SecondaryOutcomeMeasure": "Number of ICU days through Day 28",
            "SecondaryOutcomeDescription": "Number of ICU days through Day 28",
            "SecondaryOutcomeTimeFrame": "Baseline through Day 28"
          },
          {
            "SecondaryOutcomeMeasure": "Clinical status at Day 28",
            "SecondaryOutcomeDescription": "Clinical status as assessed using the Ordinal Scale for Clinical Improvement (0-8 scale, where lower score means better outcome)",
            "SecondaryOutcomeTimeFrame": "Baseline to Day 28"
          },
          {
            "SecondaryOutcomeMeasure": "Change in oxygenation",
            "SecondaryOutcomeDescription": "Change in oxygenation at Days 2, 4, 6, 14, and 28 as measured using PaO2:FiO2 ratio.",
            "SecondaryOutcomeTimeFrame": "Baseline to Day 2, Day 4, Day 6, Day 14, Day 28"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nNegative for SARS-CoV-2 infection as determined by an approved polymerase chain reaction (PCR) or an approved antigen test of any specimen\nHospitalized with non-COVID-19-induced ARDS (any severity) with a PaO2/FiO2 (PF ratio) ≤ 300\nRequires oxygen supplementation at Screening\nWilling to follow contraception guidelines\n\nExclusion Criteria:\n\nCurrent standard of care treatments for ARDS appear to be working and the subject is clinically improving\nA previous stem cell infusion unrelated to this trial\nPregnant or breast feeding or planning for either during the study\nSuspected uncontrolled active bacterial, fungal, viral, or other infection\nHistory of a splenectomy, lung transplant or lung lobectomy\nConcurrent participation in another clinical trial involving therapeutic interventions (observational study participation is acceptable)\nExpected survival or time to withdrawal of life-sustaining treatments expected to be < 7 days",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "18 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Mike Royal, MD",
            "OverallOfficialAffiliation": "Sorrento Therapeutics, Inc.",
            "OverallOfficialRole": "Study Director"
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 21, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000012128",
            "ConditionMeshTerm": "Respiratory Distress Syndrome"
          },
          {
            "ConditionMeshId": "D000012127",
            "ConditionMeshTerm": "Respiratory Distress Syndrome, Newborn"
          },
          {
            "ConditionMeshId": "D000055371",
            "ConditionMeshTerm": "Acute Lung Injury"
          },
          {
            "ConditionMeshId": "D000013577",
            "ConditionMeshTerm": "Syndrome"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000004194",
            "ConditionAncestorTerm": "Disease"
          },
          {
            "ConditionAncestorId": "D000010335",
            "ConditionAncestorTerm": "Pathologic Processes"
          },
          {
            "ConditionAncestorId": "D000008171",
            "ConditionAncestorTerm": "Lung Diseases"
          },
          {
            "ConditionAncestorId": "D000012140",
            "ConditionAncestorTerm": "Respiratory Tract Diseases"
          },
          {
            "ConditionAncestorId": "D000012120",
            "ConditionAncestorTerm": "Respiration Disorders"
          },
          {
            "ConditionAncestorId": "D000007235",
            "ConditionAncestorTerm": "Infant, Premature, Diseases"
          },
          {
            "ConditionAncestorId": "D000007232",
            "ConditionAncestorTerm": "Infant, Newborn, Diseases"
          },
          {
            "ConditionAncestorId": "D000055370",
            "ConditionAncestorTerm": "Lung Injury"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M15507",
            "ConditionBrowseLeafName": "Syndrome",
            "ConditionBrowseLeafAsFound": "Syndrome",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M2562",
            "ConditionBrowseLeafName": "COVID-19",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M14117",
            "ConditionBrowseLeafName": "Respiratory Distress Syndrome",
            "ConditionBrowseLeafAsFound": "Respiratory Distress Syndrome",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M14116",
            "ConditionBrowseLeafName": "Respiratory Distress Syndrome, Newborn",
            "ConditionBrowseLeafAsFound": "Respiratory Distress Syndrome",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M27297",
            "ConditionBrowseLeafName": "Acute Lung Injury",
            "ConditionBrowseLeafAsFound": "Acute Respiratory Distress Syndrome",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M27296",
            "ConditionBrowseLeafName": "Lung Injury",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M10320",
            "ConditionBrowseLeafName": "Lung Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M14129",
            "ConditionBrowseLeafName": "Respiratory Tract Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M14109",
            "ConditionBrowseLeafName": "Respiration Disorders",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M25022",
            "ConditionBrowseLeafName": "Premature Birth",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M9431",
            "ConditionBrowseLeafName": "Infant, Premature, Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M9428",
            "ConditionBrowseLeafName": "Infant, Newborn, Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "T4927",
            "ConditionBrowseLeafName": "Respiratory Distress Syndrome, Infant",
            "ConditionBrowseLeafAsFound": "Respiratory Distress Syndrome",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "T192",
            "ConditionBrowseLeafName": "Acute Respiratory Distress Syndrome",
            "ConditionBrowseLeafAsFound": "Acute Respiratory Distress Syndrome",
            "ConditionBrowseLeafRelevance": "high"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC23",
            "ConditionBrowseBranchName": "Symptoms and General Pathology"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC01",
            "ConditionBrowseBranchName": "Infections"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC08",
            "ConditionBrowseBranchName": "Respiratory Tract (Lung and Bronchial) Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC16",
            "ConditionBrowseBranchName": "Diseases and Abnormalities at or Before Birth"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC26",
            "ConditionBrowseBranchName": "Wounds and Injuries"
          },
          {
            "ConditionBrowseBranchAbbrev": "BXS",
            "ConditionBrowseBranchName": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "Rare",
            "ConditionBrowseBranchName": "Rare Diseases"
          }
        ]
      }
    },
    "InterventionBrowseModule": {
      "InterventionBrowseLeafList": {
        "InterventionBrowseLeaf": [
          {
            "InterventionBrowseLeafId": "M21013",
            "InterventionBrowseLeafName": "Pharmaceutical Solutions",
            "InterventionBrowseLeafRelevance": "low"
          }
        ]
      },
      "InterventionBrowseBranchList": {
        "InterventionBrowseBranch": [
          {
            "InterventionBrowseBranchAbbrev": "PhSol",
            "InterventionBrowseBranchName": "Pharmaceutical Solutions"
          },
          {
            "InterventionBrowseBranchAbbrev": "All",
            "InterventionBrowseBranchName": "All Drugs and Chemicals"
          }
        ]
      }
    }
  }
}